http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 03 Jun 2026 21:45:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Jun+02++Filed+by%3A+Barg+Steven/26601192.html si-local-file:///var/storage/secattach/20260603/26601192.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Jun+02++Filed+by%3A+Barg+Steven/26601192.html Wed, 03 Jun 2026 21:45:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Jun+02++Filed+by%3A+Barg+Steven/26601192.html si-local-file:///var/storage/secattach/20260603/26601192.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+Jun+02++Filed+by%3A+Barg+Steven/26601192.html Wed, 03 Jun 2026 21:45:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Coleman+Glenn/26592587.html si-local-file:///var/storage/secattach/20260602/26592587.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Coleman+Glenn/26592587.html Tue, 02 Jun 2026 16:46:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Coleman+Glenn/26592587.html si-local-file:///var/storage/secattach/20260602/26592587.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Coleman+Glenn/26592587.html Tue, 02 Jun 2026 16:46:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Mintz+Mark/26592516.html si-local-file:///var/storage/secattach/20260602/26592516.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Mintz+Mark/26592516.html Tue, 02 Jun 2026 16:43:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Mintz+Mark/26592516.html si-local-file:///var/storage/secattach/20260602/26592516.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Mintz+Mark/26592516.html Tue, 02 Jun 2026 16:43:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+LaPlume+Joseph+W/26592467.html si-local-file:///var/storage/secattach/20260602/26592467.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+LaPlume+Joseph+W/26592467.html Tue, 02 Jun 2026 16:40:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+LaPlume+Joseph+W/26592467.html si-local-file:///var/storage/secattach/20260602/26592467.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+LaPlume+Joseph+W/26592467.html Tue, 02 Jun 2026 16:40:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Knell+Michael+Gunnar/26592424.html si-local-file:///var/storage/secattach/20260602/26592424.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Knell+Michael+Gunnar/26592424.html Tue, 02 Jun 2026 16:38:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Knell+Michael+Gunnar/26592424.html si-local-file:///var/storage/secattach/20260602/26592424.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Knell+Michael+Gunnar/26592424.html Tue, 02 Jun 2026 16:38:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Girshick+Birgit/26592377.html si-local-file:///var/storage/secattach/20260602/26592377.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Girshick+Birgit/26592377.html Tue, 02 Jun 2026 16:35:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Girshick+Birgit/26592377.html si-local-file:///var/storage/secattach/20260602/26592377.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Girshick+Birgit/26592377.html Tue, 02 Jun 2026 16:35:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+30++Filed+by%3A+FOSTER+JAMES+C/26592253.html si-local-file:///var/storage/secattach/20260602/26592253.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+30++Filed+by%3A+FOSTER+JAMES+C/26592253.html Tue, 02 Jun 2026 16:31:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+30++Filed+by%3A+FOSTER+JAMES+C/26592253.html si-local-file:///var/storage/secattach/20260602/26592253.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+30++Filed+by%3A+FOSTER+JAMES+C/26592253.html Tue, 02 Jun 2026 16:31:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Creamer+Victoria+L/26592125.html si-local-file:///var/storage/secattach/20260602/26592125.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Creamer+Victoria+L/26592125.html Tue, 02 Jun 2026 16:27:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Creamer+Victoria+L/26592125.html si-local-file:///var/storage/secattach/20260602/26592125.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Creamer+Victoria+L/26592125.html Tue, 02 Jun 2026 16:27:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Parisotto+Shannon+M/26592084.html si-local-file:///var/storage/secattach/20260602/26592084.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Parisotto+Shannon+M/26592084.html Tue, 02 Jun 2026 16:25:00 -0400 CRL O.00066481 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Parisotto+Shannon+M/26592084.html si-local-file:///var/storage/secattach/20260602/26592084.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++CHARLES+RIVER+LABORATORI++For%3A+May+29++Filed+by%3A+Parisotto+Shannon+M/26592084.html Tue, 02 Jun 2026 16:25:00 -0400 CRL O.00066481 http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html <p>Investing.com -- Jefferies released a research report Tuesday examining artificial intelligence adoption across pharmaceutical services companies, based on analysis of 42 expert call transcripts from the past 90 days.</p><p>The firm used AI tools to review commentary on AI implementation across contract research organizations and drug development processes. Expert identities were kept anonymous with only credentials provided.</p><p>The analysis found AI produces efficiency gains that vary by development stage. Early discovery and regulatory writing showed cost savings of approximately 40% to 50%, while preclinical workflows at CROs and contract development and manufacturing organizations saw time reductions of about 40% to 50%. Later-stage http://www.streetinsider.com/AI/Jefferies+finds+AI+drives+up+to+50%25+cost+cuts+in+drug+development/26590151.html Tue, 02 Jun 2026 12:32:48 -0400 CRL IQV MEDP NVDA RTRX SDGR WST